BPG is committed to discovery and dissemination of knowledge
Open-Access Journal
Liver ultrasound elastography: More than staging the disease 
George S Gherlan 
World J Hepatol 7(12):1595-1600. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1595
Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand? 
Chrysoula Pipili, Evangelos Cholongitas 
World J Hepatol 7(12):1606-1616. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1606
Predictive factors associated with hepatitis C antiviral therapy response 
Lourianne Nascimento Cavalcante, André Castro Lyra 
World J Hepatol 7(12):1617-1631. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1617
Guide for diagnosis and treatment of hepatocellular carcinoma 
Magdy Hamed Attwa, Shahira Aly El-Etreby 
World J Hepatol 7(12):1632-1651. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1632
Systematic review: Preventive and therapeutic applications of metformin in liver disease 
Aparna Bhat, Giada Sebastiani, Mamatha Bhat 
World J Hepatol 7(12):1652-1659. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1652
Induced immunity against hepatitis B virus 
Zeinab Nabil Ahmed Said, Kouka Saadeldin Abdelwahab 
World J Hepatol 7(12):1660-1670. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1660
Occult hepatitis B virus infection in Egypt 
Ashraf Elbahrawy, Alshimaa Alaboudy, Walid El Moghazy, Ahmed Elwassief, Ahmed Alashker, Abdallah Mahmoud Abdallah 
World J Hepatol 7(12):1671-1678. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1671
Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease 
Ali Abdul-Hai, Ali Abdallah, Stephen DH Malnick 
World J Hepatol 7(12):1679-1684. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1679
Retrospective Study
Efficacy of tolvaptan in patients with refractory ascites in a clinical setting 
Takamasa Ohki, Koki Sato, Tomoharu Yamada, Mari Yamagami, Daisaku Ito, Koki Kawanishi, Kentaro Kojima, Michiharu Seki, Nobuo Toda, Kazumi Tagawa 
World J Hepatol 7(12):1685-1693. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1685
Observational Study
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 
Antonio Orlacchio, Fabrizio Chegai, Stefano Merolla, Simona Francioso, Costantino Del Giudice, Mario Angelico, Giuseppe Tisone, Giovanni Simonetti 
World J Hepatol 7(12):1694-1700. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1694
Randomized Clinical Trial
1H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy 
Konstantinos John Dabos, John Andrew Parkinson, Ian Howard Sadler, John Nicholas Plevris, Peter Clive Hayes 
World J Hepatol 7(12):1701-1707. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1701
Systematic Reviews
Hepatocellular carcinoma in Asia: Prevention strategy and planning 
Sara Ashtari, Mohamad Amin Pourhoseingholi, Afsaneh Sharifian, Mohamad Reza Zali 
World J Hepatol 7(12):1708-1717. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1708
Case Report
Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature 
Rosario Arena, Paolo Cecinato, Andrea Lisotti, Federica Buonfiglioli, Claudio Calvanese, Giuseppe Grande, Marco Montagnani, Francesco Azzaroli, Giuseppe Mazzella 
World J Hepatol 7(12):1718-1722. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1718
Letters To The Editor
Non-alcoholic fatty liver disease and beneficial effects of dietary supplements 
Ludovico Abenavoli 
World J Hepatol 7(12):1723-1724. Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1723